McHugh Damien J, Porta Nuria, Little Ross A, Cheung Susan, Watson Yvonne, Parker Geoff J M, Jayson Gordon C, O'Connor James P B
Division of Cancer Sciences, The University of Manchester, Manchester M13 9PL, UK.
Quantitative Biomedical Imaging Laboratory, The University of Manchester, Manchester M13 9PL, UK.
Cancers (Basel). 2021 Jan 11;13(2):240. doi: 10.3390/cancers13020240.
Imaging biomarkers require technical, biological, and clinical validation to be translated into robust tools in research or clinical settings. This study contributes to the technical validation of radiomic features from magnetic resonance imaging (MRI) by evaluating the repeatability of features from four MR sequences: pre-contrast T1- and T2-weighted images, pre-contrast quantitative T1 maps (qT1), and contrast-enhanced T1-weighted images. Fifty-one patients with colorectal cancer liver metastases were scanned twice, up to 7 days apart. Repeatability was quantified using the intraclass correlation coefficient (ICC) and repeatability coefficient (RC), and the impact of non-Gaussian feature distributions and image normalisation was evaluated. Most radiomic features had non-Gaussian distributions, but Box-Cox transformations enabled ICCs and RCs to be calculated appropriately for an average of 97% of features across sequences. ICCs ranged from 0.30 to 0.99, with volume and other shape features tending to be most repeatable; volume ICC > 0.98 for all sequences. 19% of features from non-normalised images exhibited significantly different ICCs in pair-wise sequence comparisons. Normalisation tended to increase ICCs for pre-contrast T1- and T2-weighted images, and decrease ICCs for qT1 maps. RCs tended to vary more between sequences than ICCs, showing that evaluations of feature performance depend on the chosen metric. This work suggests that feature-specific repeatability, from specific combinations of MR sequence and pre-processing steps, should be evaluated to select robust radiomic features as biomarkers in specific studies. In addition, as different repeatability metrics can provide different insights into a specific feature, consideration of the appropriate metric should be taken in a study-specific context.
影像生物标志物需要经过技术、生物学和临床验证,才能转化为研究或临床环境中可靠的工具。本研究通过评估来自四个磁共振成像(MRI)序列的特征的可重复性,为磁共振成像(MRI)的放射组学特征的技术验证做出了贡献:对比前T1加权和T2加权图像、对比前定量T1图(qT1)以及对比增强T1加权图像。51例结直肠癌肝转移患者接受了两次扫描,间隔时间最长为7天。使用组内相关系数(ICC)和重复性系数(RC)对可重复性进行量化,并评估非高斯特征分布和图像归一化的影响。大多数放射组学特征具有非高斯分布,但Box-Cox变换能够为各序列中平均97%的特征适当地计算ICC和RC。ICC范围为0.30至0.99,体积和其他形状特征往往最具可重复性;所有序列的体积ICC>0.98。在成对序列比较中,来自未归一化图像的19%的特征表现出显著不同的ICC。归一化倾向于增加对比前T1加权和T2加权图像的ICC,并降低qT1图的ICC。RC在各序列之间的变化往往比ICC更大,这表明特征性能的评估取决于所选的指标。这项工作表明,应评估来自MR序列和预处理步骤的特定组合的特征特异性可重复性,以选择强大的放射组学特征作为特定研究中的生物标志物。此外,由于不同的可重复性指标可以为特定特征提供不同的见解,因此应在特定研究背景下考虑适当的指标。